Anti-hemagglutinin antibodies

anti-hemagglutinin antibodies · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-hemagglutinin antibodies, covering 2017-04-24 to 2017-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People [Phase 1, Phase 2]

See pricing